Barclays PLC X Biotech Inc. Transaction History

Barclays PLC

$357 Billion
Q4 2024

A detailed history of Barclays PLC transactions in X Biotech Inc. stock. As of the latest transaction made, Barclays PLC holds 30,004 shares of XBIT stock, worth $85,511. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,004

Previous 26,343 13.9%

Holding current value

$85,511

Previous $204,000 41.67%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$3.8 - $8.25 $13,911 - $30,203	3,661 Added 13.9%	30,004 $119,000
Q3 2024 Nov 15, 2024	BUY	$5.55 - $7.95 $104,123 - $149,149	18,761 Added 247.44%	26,343 $204,000
Q2 2024 Aug 14, 2024	BUY	$4.54 - $9.89 $34,422 - $74,985	7,582 New	7,582 $39,000
Q2 2022 Aug 12, 2022	SELL	$5.13 - $9.2 $13,148 - $23,579	-2,563 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$8.64 - $11.71 $137,557 - $186,434	-15,921 Reduced 86.13%	2,563 $23,000
Q4 2021 Feb 14, 2022	BUY	$10.95 - $16.07 $133,809 - $196,375	12,220 Added 195.08%	18,484 $206,000
Q3 2021 Nov 09, 2021	BUY	$12.95 - $18.24 $55,115 - $77,629	4,256 Added 211.95%	6,264 $80,000
Q2 2021 Aug 13, 2021	SELL	$15.83 - $17.84 $161,909 - $182,467	-10,228 Reduced 83.59%	2,008 $34,000
Q1 2021 May 13, 2021	BUY	$15.92 - $20.3 $118,190 - $150,707	7,424 Added 154.28%	12,236 $210,000
Q4 2020 Feb 11, 2021	SELL	$15.65 - $19.92 $27,903 - $35,517	-1,783 Reduced 27.04%	4,812 $75,000
Q3 2020 Nov 12, 2020	SELL	$13.97 - $21.16 $18,161 - $27,508	-1,300 Reduced 16.47%	6,595 $127,000
Q2 2020 Aug 12, 2020	BUY	$10.39 - $16.07 $27,388 - $42,360	2,636 Added 50.12%	7,895 $108,000
Q1 2020 May 13, 2020	SELL	$8.89 - $24.94 $122,744 - $344,346	-13,807 Reduced 72.42%	5,259 $56,000
Q4 2019 Feb 10, 2020	BUY	$8.33 - $19.95 $26,331 - $63,061	3,161 Added 19.87%	19,066 $356,000
Q3 2019 Nov 14, 2019	BUY	$6.86 - $10.46 $11,854 - $18,074	1,728 Added 12.19%	15,905 $166,000
Q2 2019 Aug 14, 2019	SELL	$6.99 - $11.27 $456,971 - $736,776	-65,375 Reduced 82.18%	14,177 $108,000
Q1 2019 May 15, 2019	BUY	$5.05 - $11.62 $401,697 - $924,301	79,544 Added 994300.0%	79,552 $877,000
Q2 2018 Aug 14, 2018	SELL	$4.04 - $5.13 $16,604 - $21,084	-4,110 Reduced 99.81%	8 $0
Q1 2018 May 15, 2018	BUY	$3.92 - $5.35 $66 - $90	17 Added 0.41%	4,118 $21,000
Q4 2017 Feb 14, 2018	BUY	$3.9 - $4.66 $13,057 - $15,601	3,348 Added 444.62%	4,101 $16,000
Q3 2017 Nov 14, 2017	BUY	$4.14 - $5.12 $3,117 - $3,855	753	753 $3,000

Others Institutions Holding XBIT

# of Institutions

Shares Held

4.7M

Call Options Held

200

Put Options Held

12.8K

View Full List

About XBiotech Inc.

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $86.8M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

More about XBIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account